Related Experiment Video
Updated: May 26, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Castleman disease and associated autoimmune disease
Theresa W Muskardin1, Bruce A Peterson, Jerry A Molitor
1Division of Rheumatic and Autoimmune Diseases, Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Current Opinion in Rheumatology
|December 14, 2011
Summary
Castleman disease and autoimmune conditions share underlying pathology. Targeted therapies, including those against CD-20 and interleukin-6, show promise for treating both Castleman disease and associated autoimmune diseases.
Area of Science:
- Immunology
- Rheumatology
- Oncology
Background:
- Castleman disease (CD) can co-occur with autoimmune connective tissue diseases, complicating diagnosis and treatment.
- Understanding the shared pathology between CD and autoimmunity is crucial for effective management.
Purpose of the Study:
- To review the intersection of Castleman disease and autoimmunity.
- To emphasize shared pathological mechanisms and mutually beneficial treatment strategies.
Main Methods:
- Literature review focusing on studies investigating the relationship between Castleman disease and autoimmune conditions.
- Analysis of shared cellular and cytokine pathways involved in both diseases.
Main Results:
- Targeting CD-20, interleukin-6 (IL-6), and the nuclear factor-kappa B (NF-κB) pathway demonstrates potential for long-term remission.
- These targeted approaches are effective in patients with both Castleman disease and associated autoimmune features.
Conclusions:
- Advances in understanding pathogenic cells and cytokines in CD have led to targeted therapies.
- These therapies are successful in treating both Castleman disease and associated autoimmune diseases, offering a unified treatment approach.
More Related Videos
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...